Egyptian Health Minister Khaled Abdel Ghaffar discussed with representatives of the US company Bristol Myers Squibb co-operation in improving the services presented to thalassemia (Mediterranean anemia) patients.
The meeting tackled co-operation opportunities to benefit from the strategic partnership between Bristol Myers Squibb and Thalassaemia International Federation (TIF), Spokesman for the Health Ministry Hossam Abdel Ghaffar said.
The minister listed to a detailed explanation from the representatives on the proposed work plan to support the health system in Egypt especially the services presented to thalassemia patients, the spokesman said.
The minister asserted the keenness of the Ministry of Health on presenting full support to upgrading the services presented to those patients, highlighting the necessity to intensify health awareness on thalassemia disease.
Thalassemia is an inherited (passed from parents to children through genes) blood disorder caused when the body doesn’t make enough of a protein called hemoglobin, an important part of red blood cells.
